Cabaletta Bio (CABA) Cash from Operations (2018 - 2025)

Cabaletta Bio's Cash from Operations history runs 8 years deep, the most recent figure standing at 35343000.0 for Q4 2025.

• On a quarterly basis, Cash from Operations fell 52.85% year-over-year to 35343000.0 in Q4 2025; TTM through Dec 2025 was 131080000.0, a 48.58% decrease from a year earlier, with the FY2025 full-year figure at 131080000.0, down 48.58% from the prior year.
• Cash from Operations declined to 35343000.0 in Q4 2025 per CABA's latest filing, from 34509000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 6580000.0 in Q2 2021 and bottomed at 35343000.0 in Q4 2025.
• The 5-year median for Cash from Operations is 12708500.0 (2022), against an average of 17667000.0.
• Across the five-year window, Cash from Operations climbed 13.9% in 2021 and sank 90.26% in 2024, its largest moves.
• Year by year, Cash from Operations stood at 10515000.0 in 2021, then fell by 15.37% to 12131000.0 in 2022, then sank by 35.59% to 16448000.0 in 2023, then plunged by 40.58% to 23122000.0 in 2024, then slumped by 52.85% to 35343000.0 in 2025.
• Per Business Quant, the three latest CABA Cash from Operations figures stand at 35343000.0 (Q4 2025), 34509000.0 (Q3 2025), and 30426000.0 (Q2 2025).